Literature DB >> 19609056

Successful transradial antegrade coronary intervention of a rare right coronary artery high anterior downward takeoff anomalous chronic total occlusion by double-anchoring technique and retrograde guidance.

Hsiu-Yu Fang1, Cheng-Ching Wu, Chiung-Jen Wu.   

Abstract

Percutaneous coronary intervention (PCI) via a transradial approach has become feasible for the treatment of chronic total occlusion (CTO). However, abnormalities such as anomalous origin coronary arteries represent the most technically challenging cases for interventional cardiologists. In this case, we describe a CTO in a rare anomalous right coronary artery (RCA) that originated from a high anterior takeoff with downward direction; transradial recanalization was the second attempt at RCA CTO and was successfully performed by employing a double-anchoring technique with an antegrade and retrograde approach.

Entities:  

Mesh:

Year:  2009        PMID: 19609056     DOI: 10.1536/ihj.50.531

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  3 in total

Review 1.  Advances in the management of coronary chronic total occlusions.

Authors:  Emmanouil S Brilakis; Dimitri Karmpaliotis; Minh N Vo; Santiago Garcia; Lampros Michalis; Khaldoon Alaswad; Parag Doshi; William L Lombardi; Subhash Banerjee
Journal:  J Cardiovasc Transl Res       Date:  2014-03-15       Impact factor: 4.132

2.  Retrograde coronary intervention for chronic total occlusion of RCA ostium with anomalous origin: A case report.

Authors:  Ryotaro Yamada; Atsushi Hirohata; Teruyoshi Kume; Yoji Neishi; Shiro Uemura
Journal:  J Cardiol Cases       Date:  2019-02-21

Review 3.  Percutaneous treatment of a CTO in an anomalous right coronary artery: A rupture paved the way for new insights.

Authors:  Nino Cocco; Rosalinda Madonna; Valeria Cammalleri; Giulio Cocco; Domenico De Stefano; Danilo Ricciardi; Francesco Grigioni; Gian Paolo Ussia
Journal:  Front Cardiovasc Med       Date:  2022-07-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.